Ranbaxy Innovation and Growth Focus

Non-Independent Directors Board of Directors The Board of Ranbaxy has a mix of diverse experience and strong Independent Directors Dr. Tsutomu Une, Chairman 1970: Joined Daiichi. 1999: Inducted on Daiichi's BoD. 2002-06: Served as Daiichi's MD. Mr. Arun Sawhney, CEO& MD Chairman of FICCI Pharma. Committee. Founding member of Pharmaexcil. 30yrs of international experience. Mr. Takashi Shoda 2001: Director of Board of Sankyo. 2005-10: CEO & President of DS. Current Chairman of DS. Dr. Kazunori Hirokawa 2007: Head R&D, DS. 2010: Director of Board of DS. 2012: Head Corporate Strategy. Independent Directors Dr. Anthony H. Wild Till 2007: Chairman of Med Pointe. Has held senior leadership positions in Innovator companies. Mr. Rajesh V. Shah Co-Chairman and MD, Mukand. Has served as President of CII and on the Boards of ONGC, HPCL. Mr. Akhiro Watanabe Over 25 yrs exp in M&A advisory. Ex-Partner at KPMG Corp Fin. Advised on over 1,000 transactions. Mr. Percy K. Shroff 1997: MD-India Head of Elekta Instrument. Current Non-executive Chairman of Elekta Medical Systems. RANBAXY Trusted medicines.Healthier lives 32

View entire presentation